Epigenetics: The fine-tuner in inflammatory bowel disease?

Current Opinion in Gastroenterology

Volumn 29, Issue 4, 2013, Pages 370-377

  Stylianou, Eleni ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

anti inflammatory therapy; DNA methylation; epigenetics; histone modifications; inflammatory bowel diseases

Indexed keywords

ANTIINFLAMMATORY AGENT; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; CYTOKINE PRODUCTION; DNA METHYLATION; DNA MODIFICATION; DNA REPLICATION; ENTERITIS; EPIGENETICS; GENE INTERACTION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTONE MODIFICATION; HUMAN; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUMOYLATION; TRANSCRIPTION INITIATION; ULCERATIVE COLITIS;

BIOMEDICAL RESEARCH; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84879983575     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328360bd12     Document Type: Review

References (63)

1. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer 2011; 11:726-734.
2. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150:12-27.
3. Leung A, Schones DE, Natarajan R. Using epigenetic mechanisms to under-stand the impact of common disease causing alleles. Curr Opin Immunol 2012; 24:558-563.
4. Ballestar E. Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 2011; 7:263-271.
5. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46-54; e42; quiz e30.
6. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011; 365:1713-1725.
7. Scarpa M, Stylianou E. Epigenetics: concepts and relevance to IBD patho-genesis. Inflamm Bowel Dis 2012; 18:1982-1996.
8. Jenke AC, Zilbauer M. Epigenetics in inflammatory bowel disease. Curr Opin Gastroenterol 2012; 28:577-584.
9. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev 2009; 23:781-783.
10. Luger K, Mader AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389:251-260.
11. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128:693-705.
12. Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 2011; 25:2436-2452.
13. Tan M, Luo H, Lee S, et al. Identificationof67 histone marksand histone lysine crotonylation as a new type of histone modification. Cell 2011; 146:1016-1028.
14. Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med 2012; 367:647-657.
15. Gardner KE, Allis CD, Strahl BD. Operating on chromatin, acolorful language where context matters. J Mol Biol 2011; 409:36-46.
16. Turner BM. The adjustable nucleosome: an epigenetic signaling module. Trends Genet 2012; 28:436-444.
17. Whitcomb SJ, Fierz B, McGinty RK, et al. Histone monoubiquitylation position determines specificity and direction of enzymatic cross-talk with histone methyltransferases Dot1L and PRC2. J Biol Chem 2012; 287:23718-23725.
18. Jones PA. Functionsof DNA methylation: islands, startsites, gene bodiesand beyond. Nat Rev Genet 2012; 13:484-492.
19. Shukla S, Kavak E, Gregory M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011; 479:74-79.
20. Henikoff S, Shilatifard A. Histone modification: cause or cog? Trends Genet 2011; 27:389-396.
21. Shogren-Knaak M, Ishii H, Sun JM, et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006; 311:844-847.
22. Kapoor-Vazirani P, Kagey JD, Vertino PM. SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation. Mol Cell Biol 2011; 31:1594-1609.
23. Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysisof chromatin state dynamics in nine human cell types. Nature 2011; 473:43-49.
24. Zentner GE, Scacheri PC The chromatin fingerprint of gene enhancer elements. J Biol Chem 2012; 287:30888-30896.
25. Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012; 336:736-739.
26. Filippakopoulos P, Picaud S, Mangos M, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012; 149:214-231.
27. Sanchez R, Zhou MM. The PHD finger: a versatile epigenome reader. Trends Biochem Sci 2011; 36:364-372.
28. Ruthenburg AJ, Li H, Milne TA, et al. Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 2011; 145:692-706.
29. Arrowsmith CH, Bountra C, Fish PV, et al. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012; 11:384-400.
30. Katada S, Imhof A, Sassone-Corsi P. Connecting threads: epigenetics and metabolism. Cell 2012; 148:24-28.
31. Shimazu T, Hirschey MD, Newman J, et al. Suppression ofoxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013; 339:211-214.
32. Shyh-Chang N, Locasale JW, Lyssiotis CA, et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013; 339:222-226.
33. Moazed D. Mechanisms for the inheritance of chromatin states. Cell 2011; 146:510-518.
34. Daxinger L, Whitelaw E. Understanding transgenerational epigenetic inheri-tance via the gametes in mammals. Nat Rev Genet 2012; 13:153-162.
35. Petruk S, Sedkov Y, Johnston DM, et al. TrxG and PcG proteins but not methylated histones remain associated with DNA through replication. Cell 2012; 150:922-933.
36. Buckley BA, Burkhart KB, Gu SG, et al. A nuclear Argonaute promotes multigenerational epigenetic inheritance and germline immortality. Nature 2012; 489:447-451.
37. Ashe A, Sapetschnig A, Weick EM, et al. piRNAs can trigger a multigenera-tional epigenetic memory in the germline of C. elegans. Cell 2012; 150: 88-99.
38. Pujadas E, Feinberg AP. Regulated noise in the epigenetic landscape of development and disease. Cell 2012; 148:1123-1131.
39. Hansen KD, Timp W, Bravo HC, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011; 43:768-775.
40. Daigle SR, Olhava EJ, Therkelsen CA, et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 2011; 20:53-65.
41. Kruidenier L, Chung CW, Cheng Z, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012; 488:404-408.
42. Delmore JE, Issa GC, Lemieux ME, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011; 146:904-917.
43. Zuber J, Shi J, Wang E, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011; 478:524-528.
44. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-124.
45. Brant SR. Promises, delivery, and challenges of inflammatory bowel disease risk gene discovery. Clin Gastroenterol Hepatol 2013; 11:22-26.
46. Hardison RC. Genome-wide epigenetic data facilitate understanding of disease susceptibility association studies. J Biol Chem 2012; 287: 30932-30940.
47. Zwiers A, Kraal L, van de Pouw Kraan TC, et al. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J Immunol 2012; 188:1573-1577.
48. Schaible TD, Harris RA, Dowd SE, et al. Maternal methyl-donor supplementa-tion induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 2011; 20:1687-1696.
49. Nickerson KP, McDonald C. Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One 2012; 7:e52132.
50. Yin L, Chung WO. Epigenetic regulation of human beta-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol 2011; 4:409-419.
51. Wu F, Zhang S, Dassopoulos T, et al. Identification of microRNAs associated with ileal and colonicCrohn'sdisease. Inflamm Bowel Dis 2010; 16:1729-1738.
52. Wu F, Guo NJ, Tian H, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011; 17:241-250.
53. Chen Y, Ge W, Xu L, et al. miR-200bis involved in intestinalfibrosisofCrohn's disease. Int J Mol Med 2012; 29:601-606.
54. Pekow JR, Kwon JH. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:187-193.
55. Nimmo ER, Prendergast JG, Aldhous MC, et al. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis 2012; 18:889-899.
56. Cooke J, Zhang H, Greger L, et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2128-2137.
57. Hasler R, Feng Z, Backdahl L, et al. A functional methylome map of ulcerative colitis. Genome Res 2012; 22:2130-2137.
58. Sadler T, Scarpa M, Rieder F, et al. Cytokine-induced chromatin modifications of the type I collagen alpha 2 gene during intestinal endothelial to mesenchymal transition. Inflamm Bowel Dis (in press).
59. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effectson natural killer Tcell function. Science 2012;336:489-493.
60. Takahashi K, Sugi Y, Nakano K, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem 2011; 286:35755-35762.
61. Coustham V, Li P, Strange A, et al. Quantitative modulation ofpolycombsilenc-ing underlies natural variation in vernalization. Science 2012; 337:584-587.
62. Pires ND, Grossniklaus U. How to fine-tune an epigenetic switch? Dev Cell 2012; 23:453-454.
63. Mukherji S, Ebert MS, Zheng GX, et al. MicroRNAscan generatethresholdsin target gene expression. Nat Genet 2011; 43:854-859.